Skip to main content

NOVEM GROUP

Position in LLY — ELI LILLY & Co

CIK 1926783 Rochester, NY

Position in LLY

as of Jun 30, 2026 · filed Jul 21, 2026
Position Value
$2,005,446
+$429,883 QoQ
Shares Held
1,672
-2.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.64%
of 13F equity value
Holder Rank
#2,498
of 4,605 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in LLY Over Time

Shares Held

Position Value (USD)

Derivatives in LLY

reported options exposure · as of Jun 30, 2026
CallValue
$0
CallShares
0
PutValue
$119,943
PutShares
100

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

NOVEM GROUP holds $29,241,183 across 10 Drug Manufacturers - General names. LLY ranks #7 (6.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
7 LLY
ELI LILLY & Co
This page
1,672 $2,005,446

All Filings in LLY

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,005,446 1,672
2026-06-30 $119,943 100
2026-03-31 $91,977 100
2026-03-31 $1,575,563 1,713
2025-12-31 $1,630,288 1,517
2025-12-31 $214,936 200
2025-09-30 $76,300 100
2025-09-30 $1,906,737 2,499
2025-06-30 $1,958,178 2,512
2025-06-30 $77,953 100
2025-03-31 $1,299,981 1,574
2025-03-31 $82,591 100
2024-12-31 $1,313,172 1,701
2024-12-31 $154,400 200